Literature DB >> 21951640

Conserved cysteine residues in the mammalian lamin A tail are essential for cellular responses to ROS generation.

Vanja Pekovic1, Ian Gibbs-Seymour, Ewa Markiewicz, Fahad Alzoghaibi, Adam M Benham, Robert Edwards, Manfred Wenhert, Thomas von Zglinicki, Christopher J Hutchison.   

Abstract

Pre-lamin A and progerin have been implicated in normal aging, and the pathogenesis of age-related degenerative diseases is termed 'laminopathies'. Here, we show that mature lamin A has an essential role in cellular fitness and that oxidative damage to lamin A is involved in cellular senescence. Primary human dermal fibroblasts (HDFs) aged replicatively or by pro-oxidants acquire a range of dysmorphic nuclear shapes. We observed that conserved cysteine residues in the lamin A tail domain become hyperoxidized in senescent fibroblasts, which inhibits the formation of lamin A inter- and intramolecular disulfide bonds. Both in the absence of lamin A and in the presence of a lamin A cysteine-to-alanine mutant, which eliminates these cysteine residues (522, 588, and 591), mild oxidative stress induced nuclear disorganization and led to premature senescence as a result of decreased tolerance to ROS stimulators. Human dermal fibroblasts lacking lamin A or expressing the lamin A cysteine-to-alanine mutant displayed a gene expression profile of ROS-responsive genes characteristic of chronic ROS stimulation. Our findings suggest that the conserved C-terminal cysteine residues are essential for lamin A function and that loss or oxidative damage to these cysteine residues promotes cellular senescence.
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951640     DOI: 10.1111/j.1474-9726.2011.00750.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  44 in total

1.  B-type lamins and their elusive roles in metazoan cell proliferation and senescence.

Authors:  Christopher J Hutchison
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

Review 2.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

Review 3.  DNA damage and lamins.

Authors:  Susana Gonzalo
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Nuclear lamins and oxidative stress in cell proliferation and longevity.

Authors:  Takeshi Shimi; Robert D Goldman
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  Lamins in development, tissue maintenance and stress.

Authors:  Noam Zuela; Daniel Z Bar; Yosef Gruenbaum
Journal:  EMBO Rep       Date:  2012-11-13       Impact factor: 8.807

Review 6.  The nuclear lamins: flexibility in function.

Authors:  Brian Burke; Colin L Stewart
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12-05       Impact factor: 94.444

Review 7.  The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics.

Authors:  Alejandra Valdivia; Charity Duran; Alejandra San Martin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  Do lamin A and lamin C have unique roles?

Authors:  Rasha Al-Saaidi; Peter Bross
Journal:  Chromosoma       Date:  2014-10-07       Impact factor: 4.316

9.  Chemical screening identifies ATM as a target for alleviating senescence.

Authors:  Hyun Tae Kang; Joon Tae Park; Kobong Choi; Yongsub Kim; Hyo Jei Claudia Choi; Chul Won Jung; Young-Sam Lee; Sang Chul Park
Journal:  Nat Chem Biol       Date:  2017-03-27       Impact factor: 15.040

10.  Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

Authors:  Graham F Brady; Raymond Kwan; Peter J Ulintz; Phirum Nguyen; Shirin Bassirian; Venkatesha Basrur; Alexey I Nesvizhskii; Rohit Loomba; M Bishr Omary
Journal:  Hepatology       Date:  2018-03-24       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.